All the Drug Class Drugs
IgG1 kappa immunoglobulin, Monoclonal Antibody. belantamab mafodotin 100 mg. Vial. Pwder for. sol. for inf. 1 X 100 mg
In combin. with bortezomib and dexamethasone, admin. once every 3 weeks with a starting dose of 2.5 mg/kg. Combined with pomalidomide and dexamethasone, admin. once every 4 weeks with a starting dose of 2.5 mg/kg in Cycle 1. From Cycle 2 and onwards, dose at 1.9 mg/kg. See full prescription info.
in adlts for the tmt. of relapsed or refract. multiple myeloma:
• in combin. with bortezomib and dexamethasone in pts who have received at least one prior ther. • in combin. with pomalidomide and dexamethasone in pts who have received at least one prior ther. incl. lenalidomide.
C/I: Hypersens.
IgG1 kappa immunoglobulin. mogamulizumab 4 mg/ml. Conc. for sol. for inf. 1X5ml
Recommended dose is 1 mg/kg mogamulizumab as an IV inf. over at least 60 minutes. Admin. is weekly on days 1, 8, 15 and 22 of the first 28-day cycle, followed by inf. every two weeks on Days 1 and 15 of each subsequent 28-day cycle until dis. progress. or unacceptable tox.
Tmt. of adults with mycosis fungoides (MF) or Sézary syndr. (SS) who have received at least one prior syst. ther.
C/I: hypersens
